Shanghai Haohai Biological Technology Co., Ltd.

Symbol: 6826.HK

HKSE

42.45

HKD

Market price today

  • 15.1027

    P/E Ratio

  • 0.7575

    PEG Ratio

  • 16.43B

    MRK Cap

  • 0.01%

    DIV Yield

Shanghai Haohai Biological Technology Co., Ltd. (6826-HK) Financial Statements

On the chart you can see the default numbers in dynamics for Shanghai Haohai Biological Technology Co., Ltd. (6826.HK). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Shanghai Haohai Biological Technology Co., Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

balance-sheet.row.cash-and-short-term-investments

02751.12541.72907.2
3107.7
3222.5
1438.4
1797.4
2010.3
2177.8
181.3

balance-sheet.row.short-term-investments

011.16.76.4
15.1
16.5
81.3
0
9.1
140
21.3

balance-sheet.row.net-receivables

0447.6471.1375.2
340.7
390
81.3
0
0
140
83.8

balance-sheet.row.inventory

0526.2485.2354.8
255.1
240
197.6
174.9
118
78.1
76.4

balance-sheet.row.other-current-assets

025.234.169.6
116.8
76.4
576.6
413.6
360
-23.8
5.8

balance-sheet.row.total-current-assets

03750.13532.13712.6
3810
3945.4
2293.9
2386
2488.2
2372.1
347.4

balance-sheet.row.property-plant-equipment-net

015531409.61248.9
1041.7
1111.8
734.7
652.7
483.8
399.4
362.7

balance-sheet.row.goodwill

0413411.2406.9
385.5
333.5
332
410.1
292.1
0
0

balance-sheet.row.intangible-assets

0729.1783.5783.1
578.9
430.6
467.1
490.2
326.3
34.9
36.4

balance-sheet.row.goodwill-and-intangible-assets

01142.11194.71190
964.4
764.1
799.1
900.3
618.4
34.9
36.4

balance-sheet.row.long-term-investments

0596664.7619
440.4
298
510.3
108.8
55.1
-128.8
-10.7

balance-sheet.row.tax-assets

053.159.349.4
26.2
18.4
17
17.5
8.8
4.4
5.5

balance-sheet.row.other-non-current-assets

011.132130.5
16.1
14.3
81.3
10
39.1
140
10.7

balance-sheet.row.total-non-current-assets

03355.43360.33237.8
2488.7
2206.5
2142.5
1689.3
1205.2
449.9
404.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0

balance-sheet.row.total-assets

07105.56892.46950.4
6298.7
6151.9
4436.4
4075.3
3693.4
2821.9
751.9

balance-sheet.row.account-payables

055.154.546.3
28
36.8
41.2
39
19.7
4.8
8.8

balance-sheet.row.short-term-debt

0216.634.466
87.7
25.7
20.3
19.9
26.7
0
0

balance-sheet.row.tax-payables

058.452.117.8
32.9
46.6
50.9
63.1
86.3
38.5
34.9

balance-sheet.row.long-term-debt-total

0191.383.939.5
20.4
24
16.4
17.6
0
0
0

Deferred Revenue Non Current

013.65.59.4
3.5
3.6
6.2
9.1
12
14.9
17.7

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0444.2422.4375
318
297.5
389.9
418.9
442.5
136.2
130.4

balance-sheet.row.total-non-current-liabilities

0372.3478.7402.8
130.7
138.6
149.6
230.8
171.4
15.5
18.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

054.261.346.7
28.7
34.4
0
0
0
0
0

balance-sheet.row.total-liab

01088.2990890.1
564.5
498.5
600.9
708.6
707.6
156.5
157.7

balance-sheet.row.preferred-stock

071.7470
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0171.5174.1175.8
177.2
177.8
160
160
160
160
120

balance-sheet.row.retained-earnings

02728.62369.52309.7
2046.1
1846.6
1557.9
1178.8
894.8
671.5
417.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-71.7-4747.9
35.9
59.5
-225.3
-179.4
-146.2
-115.6
-83.3

balance-sheet.row.other-total-stockholders-equity

0275029713180
3231.5
3370.8
2118.8
2207.3
2077.2
1949.5
139.6

balance-sheet.row.total-stockholders-equity

05650.15514.65713.5
5490.8
5454.8
3611.5
3200.6
2904
2661.9
594.2

balance-sheet.row.total-liabilities-and-stockholders-equity

07105.56892.46950.4
6298.7
6151.9
4436.4
4075.3
3693.4
2821.9
751.9

balance-sheet.row.minority-interest

0367.2387.8346.8
243.5
198.6
223.9
166.1
81.9
3.5
0

balance-sheet.row.total-equity

06017.35902.46060.3
5734.2
5653.4
3835.4
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-

Total Investments

0607.1671.4625.3
455.5
298
591.6
108.8
64.2
11.2
21.3

balance-sheet.row.total-debt

0407.9118.3105.5
108.1
49.7
36.7
37.5
26.7
0
0

balance-sheet.row.net-debt

0-2332.1-2423.5-2795.3
-2984.5
-3172.8
-1401.8
-1759.9
-1983.6
-2177.8
-181.3

Cash Flow Statement

The financial landscape of Shanghai Haohai Biological Technology Co., Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

cash-flows.row.net-income

0508.3235.7382.6
257
434.3
525.2
461.6
365.9
320.6
215.6

cash-flows.row.depreciation-and-amortization

0197.9204.2162.8
132.9
115.4
83.6
67.7
35.8
34
22.8

cash-flows.row.deferred-income-tax

0-81.600
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

014.330.20
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

073.2-183.523.9
66.9
-40.5
-41.1
-47.1
-58.1
-16.9
-53.9

cash-flows.row.account-receivables

00-52.3-41.9
15.6
-18.9
0
0
0
0
0

cash-flows.row.inventory

0-48.4-138.9-28.6
-18.7
-27.9
-23.2
-47.3
9.7
-1.7
-33.8

cash-flows.row.account-payables

0052.341.9
-15.6
18.9
0
0
0
0
0

cash-flows.row.other-working-capital

0121.6-44.652.6
85.6
-12.6
-17.9
0.2
-67.9
-15.2
-20.2

cash-flows.row.other-non-cash-items

0-77.6-55.4-227.1
-194.7
-160.4
-176.4
-139.2
-89.1
-69.3
-42.5

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-267.2-317.1-272.1
-195.9
-399.3
-151.9
-134.7
-75.7
-70.1
-93.6

cash-flows.row.acquisitions-net

01.614.7-83.3
-88.4
-57.1
-433.8
-337.4
-246.4
-7.7
0

cash-flows.row.purchases-of-investments

0-204.2-528.8-696.6
-273.9
-1302.5
-281.6
-80.2
-1210.8
-118.7
-0.7

cash-flows.row.sales-maturities-of-investments

014.69.1749.3
649.3
166.3
433.1
382.4
4.5
38.3
0

cash-flows.row.other-investing-activites

078.6140.4154.6
225.8
456.8
-360.5
21.6
17.1
8.9
6.2

cash-flows.row.net-cash-used-for-investing-activites

0-376.6-681.8-148.1
316.9
-1135.7
-794.6
-148.4
-1511.2
-149.3
-88.2

cash-flows.row.debt-repayment

0-16.4-47.9-95.5
-49.9
-79.5
-42.3
-27.1
-4.8
0
0

cash-flows.row.common-stock-issued

073.70-4
84.8
1539.1
0
0
0
1863.7
0

cash-flows.row.common-stock-repurchased

0-270-147.7-44.9
-51
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-68.5-121.9-87.9
-124
-80
-80
-85.8
-58.6
-49.7
-70.3

cash-flows.row.other-financing-activites

0-245.729.11.1
-50
13
37
16.4
5
-59.5
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-257.7-288.4-231.3
-190.1
1392.5
-85.3
-96.5
-58.4
1754.6
-70.3

cash-flows.row.effect-of-forex-changes-on-cash

01014.2-6.9
-5.6
3.2
2.4
-1.6
2.6
4
0

cash-flows.row.net-change-in-cash

010.1-724.7-44
383.4
608.9
-486.3
96.6
-1312.5
1877.8
-16.5

cash-flows.row.cash-at-end-of-period

0569.3559.21283.9
1327.9
944.5
335.6
821.9
725.3
2037.8
160

cash-flows.row.cash-at-beginning-of-period

0559.21283.91327.9
944.5
335.6
821.9
725.3
2037.8
160
176.5

cash-flows.row.operating-cash-flow

0634.5231.3342.3
262.1
348.9
391.3
343.1
254.5
268.5
142

cash-flows.row.capital-expenditure

0-267.2-317.1-272.1
-195.9
-399.3
-151.9
-134.7
-75.7
-70.1
-93.6

cash-flows.row.free-cash-flow

0367.2-85.970.2
66.2
-50.4
239.4
208.3
178.8
198.4
48.4

Income Statement Row

Shanghai Haohai Biological Technology Co., Ltd.'s revenue saw a change of NaN% compared with the previous period. The gross profit of 6826.HK is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

income-statement-row.row.total-revenue

02634.92103.41750.1
1324.4
1595.5
1545.8
1344.9
851.2
663.9
515.9

income-statement-row.row.cost-of-revenue

0781.4656.5490.4
334
364
334.3
287.5
141.6
105.1
65.9

income-statement-row.row.gross-profit

01853.51446.91259.7
990.4
1231.5
1211.5
1057.4
709.6
558.8
450.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-4-40.3-33.9
-33.9
107.7
0.3
-16.3
-5.4
0.6
-1.6

income-statement-row.row.operating-expenses

01415.11226.81032.2
865.1
929.2
768.4
641.9
399.6
306.2
236.9

income-statement-row.row.cost-and-expenses

02196.51883.31522.5
1199.1
1293.2
1102.7
929.3
541.1
411.2
302.8

income-statement-row.row.interest-income

077.787.998.2
108.5
66.6
59.1
59.5
58.5
38.3
3.7

income-statement-row.row.interest-expense

07.37.65
4.9
4.5
2.1
2.2
0.2
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-4.7-22.9-1.8
-3.5
-3.6
82.1
46.1
55.8
68
2.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-4-40.3-33.9
-33.9
107.7
0.3
-16.3
-5.4
0.6
-1.6

income-statement-row.row.total-operating-expenses

0-4.7-22.9-1.8
-3.5
-3.6
82.1
46.1
55.8
68
2.5

income-statement-row.row.interest-expense

07.37.65
4.9
4.5
2.1
2.2
0.2
0
0

income-statement-row.row.depreciation-and-amortization

0197.9204.2162.8
132.9
115.4
83.6
67.7
35.8
34
22.8

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0513258.7384.4
260.6
438
443.1
415.5
372.9
321.4
218.2

income-statement-row.row.income-before-tax

0508.3235.7382.6
257
434.3
525.2
461.6
365.9
320.6
215.6

income-statement-row.row.income-tax-expense

09645.435.4
30.7
58
70.1
61.6
55.3
47.3
32

income-statement-row.row.net-income

0416.1180.5352.2
230.1
370.8
414.5
372.4
305.1
273.5
183.6

Frequently Asked Question

What is Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) total assets?

Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) total assets is 7105497000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.698.

What is company free cash flow?

The free cash flow is 1.049.

What is enterprise net profit margin?

The net profit margin is 0.162.

What is firm total revenue?

The total revenue is 0.177.

What is Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) net profit (net income)?

The net profit (net income) is 416121000.000.

What is firm total debt?

The total debt is 407949000.000.

What is operating expences number?

The operating expences are 1415132000.000.

What is company cash figure?

Enretprise cash is 0.000.